TapImmune completes direct public offering

TapImmune Inc. (OTCBB:TPIV), Seattle, Wash. Business: Cancer, Infectious Date completed: 2014-08-11 Type: Direct public offering Raised: $2 million Units: 1.9 million Price: $1.06 (unit) Shares after ...